Compared to pre-treatment samples, post-AZA BL-R patients showed enrichment of MYC targets, E2F targets, and DNA repair pathways (Figure 4A), and post-AZA BL-NR samples showed significant expression of cell cycle genes (Figure 4B). This evidence concerns the gene MYC and Burkitt lymphoma.